Ventricular tachycardia echocardiography
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
|
Ventricular tachycardia Microchapters |
|
Differentiating Ventricular Tachycardia from other Disorders |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Ventricular tachycardia echocardiography On the Web |
|
to Hospitals Treating Ventricular tachycardia echocardiography |
|
Risk calculators and risk factors for Ventricular tachycardia echocardiography |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Echocardiography can be performed in the patient with ventricular tachycardia to rule out structural abnormalities such as a right ventricular cardiomyopathy and silent ischemia on stress testing. Coronary arteriography is often performed in the patient with ventricular tachycardia to rule out obstructive coronary artery disease.
2006 ACC/AHA/ESC Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death (DO NOT EDIT) [1]
Left Ventricular Function and Imaging (DO NOT EDIT) [1]
| Class I |
| "1. Echocardiography is recommended in patients with ventricular arrhythmias who are suspected of having structural heart disease. (Level of Evidence B)" |
| "2. Echocardiography is recommended for the subset of patients at high risk for the development of serious ventricular arrhythmias or SCD, such as those with dilated, hypertrophic, or RV cardiomyopathies, AMI survivors, or relatives of patients with inherited disorders associated with SCD. (Level of Evidence B)" |
| "3. Exercise testing with an imaging modality (echocardiography or nuclear perfusion single-photon emission computed tomography (SPECT)) is recommended to detect silent ischemia in patients with ventricular arrhythmias who have an intermediate probability of having CHD by age, symptoms, and gender and in whom ECG assessment is less reliable because of digoxin use, LVH, greater than 1-mm ST segment depression at rest, WPW syndrome, or LBBB. (Level of Evidence B)" |
| "4. Pharmacological stress testing with an imaging modality (echocardiography or myocardial perfusion (SPECT)) is recommended to detect silent ischemia in patients with ventricular arrhythmias who have an intermediate probability of having CHD by age, symptoms, and gender and are physically unable to perform a symptom limited exercise test. (Level of Evidence B)" |
| Class IIa |
| "1. MRI, cardiac computed tomography (CT), or radionuclide angiography can be useful in patients with ventricular arrhythmias when echocardiography does not provide accurate assessment of LV and RV function and/or evaluation of structural changes. (Level of Evidence B)" |
| "2. Coronary angiography can be useful in establishing or excluding the presence of significant obstructive CHD in patients with life-threatening ventricular arrhythmias or in survivors of SCD, who have an intermediate or greater probability of having CHD by age, symptoms, and gender. (Level of Evidence C)" |
| "3. LV imaging can be useful in patients undergoing biventricular pacing. (Level of Evidence C)" |
Sources
- ACC / AHA 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death [1]
References
- ↑ 1.0 1.1 1.2 Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M; et al. (2006). "ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society". Circulation. 114 (10): e385–484. doi:10.1161/CIRCULATIONAHA.106.178233. PMID 16935995.